What Causes Memory Loss Underlying Medical Lifestyle Dietary Factors

Published

Table of Contents

Memory loss represents one of the most pressing challenges in modern neuroscience, affecting millions globally and spanning a spectrum from mild cognitive decline to devastating neurodegenerative disorders. While aging is often cited as the primary risk factor, the underlying mechanisms—ranging from pathological protein aggregation in Alzheimer’s disease to lifestyle-induced neurochemical disruptions—demand a systematic exploration. This analysis dissects the physiological, behavioral, and dietary triggers of memory impairment, integrating clinical evidence with actionable insights to clarify how interventions at each stage can mitigate cognitive decline.

The human brain’s capacity for memory relies on intricate neural networks, particularly in regions like the hippocampus and prefrontal cortex, which are vulnerable to disruption from both chronic and acute stressors. Medical conditions such as Alzheimer’s, vascular dementia, and traumatic brain injuries initiate cascades of cellular damage, including amyloid plaque formation, cerebrovascular insufficiency, and synaptic degradation. Concurrently, lifestyle factors—from chronic stress and poor sleep to alcohol abuse and physical inactivity—accelerate neurodegeneration through hormonal imbalances, metabolic dysfunction, and reduced neuroplasticity. Dietary choices further exacerbate or protect cognitive function, with processed foods and nutrient deficiencies directly impairing neural signaling and structural integrity.

what causes memory loss

Medical Conditions Linked to Memory Decline: Pathophysiological Mechanisms

Memory loss is a hallmark of neurodegenerative and cerebrovascular disorders, arising from distinct yet often overlapping pathophysiological processes. These conditions disrupt neural networks through protein misfolding, vascular compromise, or repetitive trauma, leading to progressive cognitive decline. Below, the mechanisms underlying Alzheimer’s disease, vascular dementia, Lewy body dementia, and chronic traumatic encephalopathy are examined, with a focus on their regional specificity, symptomatic progression, and neurochemical consequences.

Alzheimer’s Disease: Amyloid and Tau Pathology in Neural Disruption

Alzheimer’s disease (AD) is characterized by the accumulation of amyloid-beta (Aβ) plaques and neurofibrillary tangles composed of hyperphosphorylated tau protein, both of which disrupt synaptic function and neuronal viability. The cascade begins with amyloid precursor protein (APP) cleavage, producing Aβ peptides that aggregate into extracellular plaques, particularly in the entorhinal cortex, hippocampus, and neocortex. Concurrently, tau proteins detach from microtubules, forming intracellular tangles that destabilize axonal transport.

The following table summarizes the key pathologies, affected brain regions, symptomatic stages, and neurochemical impacts:

Pathology Brain Region Affected Symptomatic Stage Neurochemical Impact
Amyloid-beta plaques (Aβ42) Entorhinal cortex → Hippocampus → Neocortex Early: Mild cognitive impairment (MCI); Late: Severe dementia Synaptic dysfunction via glutamate excitotoxicity, inflammatory cytokine release (IL-1β, TNF-α)
Tau tangles (p-tau) Hippocampal CA1, basal forebrain cholinergic nuclei Early: Episodic memory deficits; Late: Global cognitive decline Microtubule destabilization → Axonal transport failure; Cholinergic neuron loss (ACh depletion)
Key Insight:
The interplay between Aβ and tau accelerates neurodegeneration through a vicious cycle: Aβ triggers tau misfolding, while tau exacerbates Aβ toxicity, culminating in synaptic loss and neuronal death. This dual-pathology model explains why AD progresses from regional memory deficits to widespread cognitive impairment.

Vascular Dementia: Cerebrovascular Events and White Matter Degeneration

Vascular dementia (VaD) results from chronic hypoperfusion or ischemic events that disrupt white matter integrity, particularly in frontal-subcortical circuits critical for executive function and memory retrieval. The pathophysiological sequence begins with large-vessel strokes (e.g., middle cerebral artery occlusion) or small-vessel disease (e.g., lacunar infarcts, microinfarcts), leading to white matter hyperintensities on MRI.

The following flowchart outlines the stages of vascular memory impairment:

1. Initial Damage

  • Cerebrovascular events (e.g., thromboembolism, hypertension-induced microbleeds) reduce cerebral blood flow (CBF) to strategic regions.
  • White matter lesions (e.g., periventricular or deep white matter) emerge due to blood-brain barrier (BBB) breakdown and lipohyalinosis (hyaline thickening of vessel walls).

    • 2. Oxygen Deprivation

  • Hypoxia activates hypoxia-inducible factor 1-alpha (HIF-1α), triggering inflammatory cascades (e.g., matrix metalloproteinases, reactive oxygen species).
  • Oligodendrocyte dysfunction leads to myelin sheath degradation, impairing axonal conduction in the corpus callosum and frontal lobes.

    • 3. Neural Circuit Disruption

  • Frontal-subcortical disconnection: Disrupted connectivity between the dorsolateral prefrontal cortex (DLPFC) and basal ganglia impairs working memory and attention.
  • Hippocampal vulnerability: Chronic hypoperfusion reduces neurogenesis in the dentate gyrus, accelerating episodic memory decline.

    • Clinical Correlation:
    Patients with VaD exhibit subcortical dementia syndrome, characterized by:

  • Slow processing speed (due to white matter disconnection).
  • Executive dysfunction (e.g., difficulty with task-switching, planning).
  • Gait abnormalities (linked to vascular Parkinsonism from basal ganglia ischemia).

    • Lewy Body Dementia and Parkinson’s Disease: Alpha-Synuclein and Dopaminergic Depletion

    Both Lewy body dementia (LBD) and Parkinson’s disease dementia (PDD) involve alpha-synuclein aggregation, but their memory profiles differ due to regional deposition patterns and dopaminergic vs. cholinergic dysfunction. While PDD typically follows motor symptoms by ≥1 year, LBD presents with early cognitive impairment, including visual hallucinations and fluctuating attention.

    Comparative Pathophysiology:

    FeatureLewy Body Dementia (LBD)Parkinson’s Disease Dementia (PDD)
    Alpha-synucleinCortical (temporal, parietal) + limbic depositionSubstantia nigra → Cortical spread (later stage)
    Memory DomainEpisodic memory (hippocampal atrophy)Procedural memory (striatal dopamine loss)
    NeurotransmitterCholinergic deficit (nucleus basalis of Meynert)Dopaminergic deficit (substantia nigra pars compacta)
    Symptomatic OnsetCognitive decline precedes motor symptomsCognitive decline follows motor symptoms
    Mechanistic Insight:
    In LBD, alpha-synuclein aggregates in the temporoparietal cortex and amygdala, disrupting cholinergic projections to the hippocampus, leading to rapid episodic memory decline. Conversely, PDD’s memory deficits arise from striatal dopamine depletion, impairing habit learning and motor sequencing (procedural memory) while sparing episodic recall until late stages.
    Distinct Cognitive Profiles:
  • LBD: Early visual hallucinations, REM sleep behavior disorder (RBD), and fluctuating cognition (e.g., "freezing" of attention).
  • PDD: Bradyphrenia (slowed thought processes), apathy, and preserved semantic memory until advanced stages.

    • Chronic Traumatic Encephalopathy: Hippocampal Atrophy and Delayed Cognitive Decline

    Chronic traumatic encephalopathy (CTE) is a progressive tauopathy linked to repetitive brain trauma, most commonly observed in contact sports athletes, military personnel, and abuse survivors. Unlike AD, CTE tau pathology is perivascular and sulcal, with a stage-dependent distribution:

    1. Stage I (Mild):

  • Diffuse axonal injury (DAI) from concussive forces.
  • Hippocampal and entorhinal cortex show neurofibrillary tangles (NFTs).
  • Symptoms: Mild memory lapses, irritability, anxiety.

    • 2. Stage II (Moderate):

  • Tau accumulation in the medial temporal lobe (MTL) and dorsal raphe nucleus.
  • White matter degeneration in the corpus callosum.
  • Symptoms: Executive dysfunction, emotional dysregulation, early dementia.

    • 3. Stage III/IV (Severe):

  • Widespread NFTs in frontal and temporal lobes, amygdala, and basal ganglia.
  • Hippocampal atrophy (>20% volume loss on MRI).
  • Symptoms: Severe memory loss, dementia, parkinsonism, suicidal ideation.

    • Key Pathogenic Mechanisms:

    CTE progression is driven by:
  • Tau misfolding triggered by mechanical stress (e.g., axonal stretching during concussions).
  • Neuroinflammation (microglial activation via TLR4 signaling).
  • Hippocampal vulnerability due to its high metabolic demand and limited vascular reserve.
    • The delayed onset (often decades post-trauma) reflects tau propagation along perivascular spaces, a process distinct from AD’s amyloid-driven pathology.
    Real-World Example:
    A study of NFL players revealed that those with ≥3 concussions had a 4.5-fold increased risk

    what causes memory loss - Ilustrasi 2

    Lifestyle Factors Influencing Cognitive Decline

    Lifestyle choices exert profound and often reversible effects on memory and cognitive function through biochemical, neurovascular, and synaptic mechanisms. Chronic exposure to adverse lifestyle factors—such as stress, sleep deprivation, substance misuse, and physical inactivity—disrupts hippocampal neurogenesis, synaptic plasticity, and metabolic homeostasis, accelerating memory decline. Below, the pathophysiological pathways underlying these influences are examined, with emphasis on glucocorticoid dysregulation, sleep-stage-dependent memory consolidation, neurotoxic effects of alcohol, and cerebrovascular consequences of sedentary behavior.

    Chronic Stress and Hippocampal Neuron Loss via Glucocorticoid Dysregulation

    Prolonged activation of the hypothalamic-pituitary-adrenal (HPA) axis, driven by elevated cortisol levels, induces structural and functional damage to the hippocampus, a brain region critical for episodic and spatial memory. The mechanism involves glucocorticoid receptor (GR) dysregulation, where chronic cortisol exposure leads to:
  • Downregulation of mineralocorticoid receptors (MRs), reducing negative feedback on the HPA axis and sustaining hypercortisolemia.
  • Oxidative stress via cortisol-induced mitochondrial dysfunction, particularly in CA3 pyramidal neurons.
  • Synaptic remodeling through excessive activation of GRs, which promotes dendritic atrophy and reduced neurogenesis in the dentate gyrus.
    • Key Pathway:
    Cortisol → GR overactivation → Increased production of pro-inflammatory cytokines (IL-6, TNF-α) → Reduced BDNF expression → Synaptic pruning and neuron loss.
    The following table summarizes stress-induced memory impairment pathways:
    Stress Type Hormonal Trigger Brain Region Affected Memory Function Impaired
    Acute Psychological Stress Elevated cortisol, adrenaline Prefrontal cortex, hippocampus Working memory, contextual fear memory
    Chronic Systemic Stress (e.g., caregiving, PTSD) Dysregulated GR/MR balance, elevated IL-1β Hippocampal CA3, dentate gyrus Episodic memory, pattern separation
    Metabolic Stress (e.g., obesity, diabetes) Insulin resistance, elevated glucocorticoids Hippocampus, basal forebrain Semantic memory, encoding deficits
    Supporting Evidence:
  • A 2020 Nature Reviews Neuroscience study demonstrated that chronic unpredictable stress in rodents reduced hippocampal volume by 25% within 4 weeks, correlating with impaired spatial memory in the Morris water maze.
  • Human neuroimaging studies (Journal of Neuroscience, 2019) linked childhood adversity to reduced hippocampal gray matter in adulthood, with effects persisting into old age.

    • Poor Sleep Hygiene and Disrupted Memory Consolidation

    Memory consolidation relies on sleep-stage-specific processes, particularly slow-wave sleep (NREM Stage 3) and rapid eye movement (REM) sleep, which facilitate synaptic plasticity and glycogen metabolism. Disruptions in sleep architecture—common in insomnia, shift work, or circadian misalignment—impair memory through:
  • Adenosine accumulation: Sleep deprivation elevates extracellular adenosine, inhibiting glutamate release and reducing long-term potentiation (LTP) in the hippocampus.
  • Glycogen depletion: Astrocytic glycogen, critical for neuronal energy during sleep, is depleted in sleep-deprived states, leading to reduced synaptic plasticity.
  • REM sleep suppression: REM sleep is essential for emotional memory processing; its loss (e.g., in depression or sleep apnea) correlates with increased amygdala reactivity and impaired declarative memory.
    • Sleep-Stage Functions:
  • NREM Stage 3: Procedural memory consolidation via spindle-sharp wave complexes.
  • REM Sleep: Emotional memory integration through acetylcholine-mediated synaptic remodeling.
    • Long-Term Consequences:
  • Chronic sleep restriction (<6 hours/night) reduces hippocampal volume by 1–2% annually (Sleep Medicine Reviews, 2017).
  • Shift work disorder increases dementia risk by 45% due to disrupted melatonin-cortisol rhythms (Journal of Alzheimer’s Disease, 2018), with accelerated tau pathology in animal models.

    • Alcohol-Induced Memory Impairment: Heavy Use vs. Moderate Social Drinking

    Alcohol’s neurotoxic effects on memory differ markedly between heavy chronic consumption and moderate social drinking, with distinct pathophysiological mechanisms:

    Heavy Alcohol Consumption (≥60g/day):

  • Thiamine (Vitamin B1) Deficiency: Impairs pyruvate dehydrogenase, leading to lactic acidosis and Wernicke-Korsakoff syndrome (WKS), characterized by:
  • Mammillary body atrophy (critical for memory retrieval).
  • Dorsomedial thalamic degeneration (disrupting prefrontal-hippocampal circuits).
  • Frontal Lobe Atrophy: Chronic alcohol exposure reduces gray matter volume in the dorsolateral prefrontal cortex (DLPFC), impairing executive function and working memory.
  • N-Methyl-D-Aspartate (NMDA) Receptor Dysfunction: Alcohol inhibits NMDA receptors, reducing BDNF expression and hippocampal neurogenesis.

    • Moderate Social Drinking (<14g/day):

  • No significant structural damage observed in neuroimaging studies (Alcoholism: Clinical & Experimental Research, 2021).
  • Potential cognitive benefits via resveratrol-like effects (e.g., red wine polyphenols enhancing cerebral blood flow).
  • Minimal thiamine deficiency risk unless accompanied by poor nutrition.
    • WKS Progression Stages:
    1. Wernicke’s Encephalopathy: Acute confusion, ataxia, ophthalmoplegia (reversible with thiamine).
    2. Korsakoff’s Psychosis: Chronic anterograde/retrograde amnesia (permanent if untreated).
    Key Study:
  • A 2022 Lancet Psychiatry meta-analysis found that long-term heavy drinking reduced hippocampal volume by 10–15%, while moderate drinkers showed no significant atrophy compared to abstainers.

    • Sedentary Lifestyle and Cerebrovascular-Mediated Memory Decline

    Physical inactivity contributes to memory loss primarily through reduced cerebral blood flow (CBF), downregulated neurotrophic support, and hippocampal atrophy. The mechanisms include:
  • Cerebrovascular Dysfunction: Sedentary individuals exhibit lower CBF velocity in the posterior cerebral artery, reducing oxygen and glucose delivery to the hippocampus (Journal of Alzheimer’s Disease, 2018).
  • BDNF Downregulation: Inactive individuals show reduced serum BDNF levels, impairing synaptic plasticity and adult neurogenesis.
  • Hippocampal Volume Loss: Cross-sectional studies link low cardiorespiratory fitness to 1–2% smaller hippocampal volumes per decade (Neurology, 2020).
    • Exercise-Induced Neuroprotection:
  • Aerobic exercise increases angiogenic factors (VEGF, FGF-2), enhancing neurovascular coupling.
  • Resistance training boosts IGF-1, promoting hippocampal synaptic density.
    • Supporting Evidence:
  • A 12-week intervention in sedentary adults (Brain Plasticity, 2019) showed that brisk walking 3x/week increased hippocampal volume by 2% and improved spatial memory performance.
  • Animal studies (Nature Neuroscience, 2014) demonstrated that voluntary wheel running in mice doubled BDNF levels and enhanced LTP in the hippocampus.

    • what causes memory loss - Ilustrasi 3

    Nutritional and Dietary Triggers of Memory Decline

    Dietary patterns play a pivotal role in modulating cognitive function, with specific nutrients either preserving or compromising neural integrity. While certain foods enhance memory through neuroprotective mechanisms, others accelerate decline via oxidative stress, neuroinflammation, or vascular damage. This section examines the pathophysiological pathways by which dietary components disrupt memory, categorized by their primary mechanism of action. Understanding these triggers allows for targeted dietary interventions to mitigate cognitive impairment.

    The interplay between nutrition and memory extends beyond caloric intake, involving metabolic, inflammatory, and structural changes in the brain. For instance, chronic consumption of processed foods and high-glycemic diets disrupts hippocampal neurogenesis and synaptic plasticity, while deficiencies in essential micronutrients (e.g., B vitamins) impair myelin integrity and neurotransmitter synthesis. Conversely, Mediterranean diet components—rich in polyphenols, omega-3s, and monounsaturated fats—promote neurogenesis and reduce amyloid-beta accumulation. Below, structured analyses highlight the most critical dietary triggers and protective pathways.

    Foods Exacerbating Memory Loss by Mechanism

    Dietary components contribute to memory decline through distinct pathophysiological routes, primarily oxidative stress, neuroinflammation, and vascular damage. The following table categorizes high-risk foods by mechanism, brain region impacted, and associated memory dysfunction, supported by epidemiological and preclinical evidence.
    Food Group Mechanism Brain Region Impacted Memory Function Affected
    Trans fats (partially hydrogenated oils) Oxidative stress via lipid peroxidation; disrupts mitochondrial function Prefrontal cortex, hippocampus Working memory, episodic recall
    Refined sugars (high-fructose corn syrup, sucrose) Hyperglycemia-induced oxidative stress; advanced glycation end products (AGEs) Hippocampus, basal forebrain Spatial memory, attention
    Processed meats (bacon, sausages, deli meats) Vascular damage via nitrosamines; endothelial dysfunction Cerebral cortex, subcortical white matter Executive function, processing speed
    High-glycemic index foods (white bread, pastries) Neuroinflammation via microglial activation; insulin resistance in the brain Hippocampus, amygdala Contextual fear memory, long-term potentiation
    Fried foods (deep-fried fast foods) Oxidative stress and neuroinflammation via advanced lipid oxidation products (ALEs) Entorhinal cortex, cerebellum Semantic memory, motor learning
    Artificial sweeteners (aspartame, saccharin) Disrupts gut-brain axis; alters microbiome composition linked to neuroinflammation Hypothalamus, prefrontal cortex Cognitive flexibility, decision-making
    Key Insight: The cumulative effect of these dietary patterns is amplified in aging populations, where baseline cognitive reserve is reduced. For example, a 2018 meta-analysis in Neurology demonstrated that high intake of processed meats increased dementia risk by 44%, independent of other vascular factors.

    Neurochemical Pathways in Vitamin B12 Deficiency-Induced Memory Impairment

    Vitamin B12 (cobalamin) deficiency is a reversible yet underdiagnosed cause of cognitive decline, particularly in older adults and vegetarians. Its impact on memory arises from disrupted methyl group metabolism, leading to neurotoxic byproducts and myelin degradation. The following neurochemical cascade elucidates the mechanism:

    1. Dietary Deficiency: Inadequate B12 intake (e.g., <2.5 µg/day) or malabsorption (e.g., pernicious anemia) reduces methylcobalamin availability.
    2. Methylmalonic Acid (MMA) Accumulation: B12-dependent methylmalonyl-CoA mutase is inhibited, elevating MMA levels, which impair mitochondrial energy production.
    3. Homocysteine Buildup: Methionine synthase activity declines, increasing homocysteine concentrations. Elevated homocysteine promotes:

  • Oxidative stress via peroxynitrite formation.
  • Endothelial dysfunction through reduced nitric oxide bioavailability.
    • 4. Myelin Sheath Degradation: Homocysteine induces apoptosis of oligodendrocytes, disrupting white matter integrity in the corpus callosum and prefrontal cortex.
    5. Executive Dysfunction: Neuronal apoptosis in the dorsolateral prefrontal cortex impairs working memory and cognitive control, while hippocampal atrophy affects episodic memory.

    Diagram Description:
    A linear process starting with dietary deficiency → methylmalonic acid accumulation → mitochondrial dysfunction (reduced ATP production) → neuronal apoptosis in the prefrontal cortex and hippocampus → executive dysfunction and memory consolidation deficits.

    Clinical Correlation: A 2020 study in The Lancet Neurology found that B12-deficient patients exhibited a 30% reduction in prefrontal cortex volume, correlating with impaired Stroop task performance. Repletion therapy (e.g., intramuscular cyanocobalamin) can partially reverse these deficits within 6–12 months.

    Mechanisms of Sugar-Induced Memory Disruption via Insulin Resistance

    Excessive sugar consumption, particularly high-fructose diets, impairs memory through insulin resistance in the brain, a condition termed "cerebral insulin resistance." This pathway involves:
    1. Hippocampal Glucose Metabolism Dysregulation: The hippocampus, critical for memory formation, relies on insulin to regulate glucose uptake. Chronic hyperglycemia saturates insulin receptors, reducing glucose availability for synaptic plasticity.
    2. Advanced Glycation End Products (AGEs): Excess glucose reacts with proteins/lipids to form AGEs, which:
  • Cross-link collagen in the extracellular matrix, reducing neurotrophic support.
  • Activate receptor for AGEs (RAGE), triggering NF-κB-mediated neuroinflammation.
    • 3. Synaptic Dysfunction: AGEs and oxidative stress impair long-term potentiation (LTP) in the CA1 region of the hippocampus, essential for memory consolidation.
    4. Neurodegeneration: AGEs accumulate in amyloid plaques, accelerating Alzheimer’s pathology. A 2019 Nature study demonstrated that AGEs reduced dendritic spine density in rodent models by 40%.

    Hippocampal Vulnerability:
    The hippocampus expresses high levels of glucose transporter 3 (GLUT3), making it particularly sensitive to insulin resistance. In type 2 diabetes patients, hippocampal volume loss correlates with HbA1c levels, with each 1% increase in HbA1c associated with a 2% reduction in memory performance.

    Comparison of Mediterranean and Western Diets in Cognitive Protection

    Dietary patterns significantly influence cognitive aging, with the Mediterranean diet (MedDiet) associated with a 30–50% lower risk of dementia compared to Western diets. The following comparison highlights key neuroprotective components and mechanisms:

    Mediterranean Diet:

  • Olive Oil (Monounsaturated Fats):
  • Mechanism: Rich in oleocanthal, which inhibits NF-κB and reduces amyloid-beta aggregation.
  • Pathway: Enhances BDNF (brain-derived neurotrophic factor) via PPAR-γ activation, promoting hippocampal neurogenesis.
  • Omega-3 Fatty Acids (Fish, Nuts):
  • Mechanism: DHA and EPA incorporate into neuronal membranes, reducing membrane fluidity and oxidative stress.
  • Pathway: Downregulates pro-inflammatory cytokines (IL-6, TNF-α) and upregulates anti-inflammatory resolvins.
  • Polyphenols (Berries, Green Tea):
  • Mechanism: Anthocyanins and EGCG cross the blood-brain barrier, scavenging ROS and modulating microglial activity.
  • Pathway: Enhances LTP and synaptic plasticity via PI3K/Akt signaling.
  • Whole Grains and Legumes:
  • Mechanism: High fiber content supports gut microbiome diversity, reducing systemic inflammation.
  • Pathway: Short-chain fatty acids (e.g., butyrate) enhance blood-brain barrier integrity.

    • Western Diet:

  • Refined Carbohydrates and Sugars:
  • Mechanism: Promote cerebral insulin resistance and AGEs, as detailed above.
  • Processed Meats and Saturated

    The causes of memory loss are multifaceted, reflecting a convergence of genetic predispositions, environmental exposures, and modifiable behaviors. Medical interventions targeting amyloid plaques, vascular risk factors, or alpha-synuclein aggregation offer critical pathways for early diagnosis and therapeutic progress, yet their efficacy hinges on timely detection. Lifestyle modifications—such as stress management, prioritizing sleep hygiene, and adopting physically active routines—provide accessible strategies to preserve cognitive resilience. Dietary adjustments, particularly the adoption of Mediterranean diet principles, underscore the brain’s dependency on nutrient-dense foods to sustain synaptic function and mitigate neuroinflammation. Ultimately, addressing memory loss requires a holistic approach that integrates medical advancements with proactive lifestyle and nutritional choices, ensuring long-term cognitive health in an aging population.

    • FAQ

    what causes memory loss and forgetfulness?

    Q: What are the common causes of memory loss and forgetfulness?

    what causes memory loss in young adults?

    Q: What are the possible causes of memory loss in young adults?

    what causes memory loss in old age?

    Q: What causes memory loss in old age?

    what causes memory loss and forgetfulness at a young age?

    Q: What causes memory loss and forgetfulness at a young age?

    what causes memory loss at a young age?

    Q: What causes memory loss at a young age?

    what causes memory loss and confusion?

    Q: What causes memory loss and confusion?